{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T12:06:56Z","timestamp":1789474016146,"version":"build-2803163510"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T00:00:00Z","timestamp":1780444800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Secretar\u00eda de Ciencia, Humanidades, Tecnolog\u00eda e Innovaci\u00f3n","doi-asserted-by":"publisher","award":["2019-64382"],"award-info":[{"award-number":["2019-64382"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005739","name":"Universidad Nacional Aut\u00f3noma de M\u00e9xico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005739","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Brain, Behavior, and Immunity"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.bbi.2026.106840","type":"journal-article","created":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T16:28:18Z","timestamp":1780417698000},"page":"106840","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Pramipexole promotes CD8+ regulatory T cell-dependent neuroprotection in Parkinson\u2019s disease patients"],"prefix":"10.1016","volume":"137","author":[{"given":"Edwin","family":"Gallegos-Altamirano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Castillo-Arellano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erandi","family":"P\u00e9rez Figueroa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri\u00e1n","family":"Guevara-Salinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emiliano","family":"Gonz\u00e1lez-Vilchis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Morales-Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"\u00c1lvarez-Luquin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayela","family":"Rodr\u00edguez-Violante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Ichikawa-Escamilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9s Yamil","family":"Regalado-Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e1maris","family":"Romero-Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eduardo","family":"Mart\u00ednez-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"Velasco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Adalid-Peralta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"593026","key":"10.1016\/j.bbi.2026.106840_b0005","article-title":"Blood-brain barrier leakage is increased in Parkinson\u2019s disease","volume":"11","author":"Al-Bachari","year":"2020","journal-title":"Front. Physiol."},{"issue":"8","key":"10.1016\/j.bbi.2026.106840_b0010","doi-asserted-by":"crossref","first-page":"749","DOI":"10.33588\/rn.3608.2002275","article-title":"Factores de riesgo de la enfermedad de Parkinson","volume":"36","author":"Allam","year":"2003","journal-title":"Rev. Neurol."},{"issue":"1","key":"10.1016\/j.bbi.2026.106840_b0015","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1186\/s12974-019-1606-1","article-title":"Regulatory impairment in untreated Parkinson's disease is not restricted to Tregs: other regulatory populations are also involved","volume":"16","author":"\u00c1lvarez","year":"2019","journal-title":"J. Neuroinflam."},{"key":"10.1016\/j.bbi.2026.106840_b0020","first-page":"1","article-title":"Genetic changes in regulatory immune cells induced by pramipexole and rotigotine: implications for the treatment of Parkinson\u2019s disease","author":"\u00c1lvarez-Luqu\u00edn","year":"2025","journal-title":"Inflammopharmacology"},{"issue":"8","key":"10.1016\/j.bbi.2026.106840_b0025","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1007\/s00702-024-02790-2","article-title":"Increased levels of regulatory T cells and IL-10-producing regulatory B cells are linked to improved clinical outcome in Parkinson\u2019s disease: a 1-year observational study","volume":"131","author":"Arce-Sillas","year":"2024","journal-title":"J. Neural Transm."},{"issue":"3","key":"10.1016\/j.bbi.2026.106840_b0030","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1159\/000501187","article-title":"Expression of dopamine receptors in immune regulatory cells","volume":"26","author":"Arce-Sillas","year":"2019","journal-title":"Neuroimmunomodulation"},{"issue":"1\u20132","key":"10.1016\/j.bbi.2026.106840_b0035","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jneuroim.2005.07.013","article-title":"Dopamine by itself activates either D2, D3 or D1\/D5 dopaminergic receptors in normal human T-cells and triggers the selective secretion of either IL-10, TNF\u03b1 or both","volume":"169","author":"Besser","year":"2005","journal-title":"J. Neuroimmunol."},{"issue":"3","key":"10.1016\/j.bbi.2026.106840_b0040","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1517\/13543784.2014.869209","article-title":"Dopamine receptor agonists for Parkinson's disease","volume":"23","author":"Blandini","year":"2014","journal-title":"Expert Opin. Invest. Drugs"},{"issue":"12","key":"10.1016\/j.bbi.2026.106840_b0050","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.4103\/1673-5374.284976","article-title":"Dopamine: an immune transmitter","volume":"15","author":"Broome","year":"2020","journal-title":"Neural Regen. Res."},{"issue":"8","key":"10.1016\/j.bbi.2026.106840_b0055","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/mdc3.12840","article-title":"Gut vibes in Parkinson's disease: the microbiota\u2010gut\u2010brain axis","volume":"6","author":"Bullich","year":"2019","journal-title":"Move. Disord. Clin. Practice"},{"key":"10.1016\/j.bbi.2026.106840_b0060","doi-asserted-by":"crossref","first-page":"239","DOI":"10.3389\/fimmu.2019.00239","article-title":"T-cell-driven inflammation as a mediator of the gut-brain axis involved in Parkinson's disease","volume":"10","author":"Campos-Acu\u00f1a","year":"2019","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.bbi.2026.106840_b0065","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.nrl.2011.04.012","article-title":"Agonistas dopamin\u00e9rgicos en la enfermedad de Parkinson","volume":"29","author":"C\u00e1novas","year":"2014","journal-title":"Neurolog\u00eda"},{"issue":"10","key":"10.1016\/j.bbi.2026.106840_b0070","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/nrd.2018.133","article-title":"Therapeutic approaches to Huntington disease: from the bench to the clinic","volume":"17","author":"Caron","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"18","key":"10.1016\/j.bbi.2026.106840_b0075","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1080\/14656566.2020.1805432","article-title":"An update on the use of non-ergot dopamine agonists for the treatment of Parkinson\u2019s disease","volume":"21","author":"Cerri","year":"2020","journal-title":"Expert Opin. Pharmacother."},{"key":"10.1016\/j.bbi.2026.106840_b0080","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3389\/fnmol.2019.00218","article-title":"Gut inflammation in association with pathogenesis of Parkinson\u2019s disease","volume":"12","author":"Chen","year":"2019","journal-title":"Front. Mol. Neurosci."},{"key":"10.1016\/j.bbi.2026.106840_b0085","unstructured":"Chen, Y., Yu, M., Liu, X., Qu, H., Chen, Q., Qian, W., ... & Wu, W. (2015). Clinical characteristics and peripheral T cell subsets in Parkinson\u2019s disease patients with constipation. International journal of clinical and experimental pathology, 8(3), 2495. PMID: 26045755; PMCID: PMC4440064."},{"key":"10.1016\/j.bbi.2026.106840_b0090","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/s41598-018-19646-x","article-title":"Oral administration of Proteus mirabilis damages dopaminergic neurons and motor functions in mice","volume":"8","author":"Choi","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbi.2026.106840_b0095","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1038\/s41401-022-00951-1","article-title":"Pramipexole inhibits astrocytic NLRP3 inflammasome activation via Drd3-dependent autophagy in a mouse model of Parkinson\u2019s disease","volume":"44","author":"Dong","year":"2023","journal-title":"Acta Pharmacol. Sin."},{"issue":"2","key":"10.1016\/j.bbi.2026.106840_b0100","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s00401-012-1004-6","article-title":"Protein degradation pathways in Parkinson\u2019s disease: curse or blessing","volume":"124","author":"Ebrahimi","year":"2012","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbi.2026.106840_b0105","doi-asserted-by":"crossref","unstructured":"Espinosa R, Arce A, \u00c1lvarez D, Leyva J, Montes E, Gonz\u00e1lezI, Boll MC, Garcia E, \u00c1ngeles S, Fragoso G, Sciutto E, Adalid L. (2020). Immunomodulatory effect and clinical outcome in Parkinson's disease patients on levodopa-pramipexole combo therapy: A two-year prospective study. J. Neuroimmunol. 2020 Oct 15;347:577328. doi: 10.1016\/j.jneuroim.2020.577328.","DOI":"10.1016\/j.jneuroim.2020.577328"},{"key":"10.1016\/j.bbi.2026.106840_b0110","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0028032","article-title":"Increased intestinal permeability correlates with sigmoid mucosa alpha-synuclein staining and endotoxin exposure markers in early Parkinson's disease","volume":"6","author":"Forsyth","year":"2011","journal-title":"PLoS One"},{"issue":"10","key":"10.1016\/j.bbi.2026.106840_b0115","doi-asserted-by":"crossref","first-page":"e1469","DOI":"10.1002\/cti2.1469","article-title":"Dopaminergic regulation of inflammation and immunity in Parkinson's disease: friend or foe?","volume":"12","author":"Furgiuele","year":"2023","journal-title":"Clin. Transl. Immunol."},{"issue":"8","key":"10.1016\/j.bbi.2026.106840_b0120","doi-asserted-by":"crossref","DOI":"10.1111\/cns.14883","article-title":"Treating activated regulatory T cells with pramipexole protects human dopaminergic neurons from 6\u2010OHDA\u2010induced degeneration","volume":"30","author":"Guevara-Salinas","year":"2024","journal-title":"CNS Neurosci. Ther."},{"key":"10.1016\/j.bbi.2026.106840_b0125","first-page":"1","article-title":"Periphery and brain, innate and adaptive immunity in Parkinson\u2019s disease","author":"Harms","year":"2021","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.bbi.2026.106840_b0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142164","article-title":"Intestinal dysbiosis and lowered serum lipopolysaccharide-binding protein in Parkinson's disease","volume":"10","author":"Hasegawa","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbi.2026.106840_b0135","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.3389\/fimmu.2020.01869","article-title":"Critical neurotransmitters in the neuroimmune network","volume":"11","author":"Hodo","year":"2020","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.bbi.2026.106840_b0140","first-page":"491","article-title":"Dopamine receptors modulate T lymphocytes via inhibition of cAMP-CREB signaling pathway","volume":"37","author":"Huang","year":"2016","journal-title":"Neuroendocrinol. Lett."},{"issue":"8","key":"10.1016\/j.bbi.2026.106840_b0145","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.neuint.2009.07.009","article-title":"Neuroprotective effect of the antiparkinsonian drug pramipexole against nigrostriatal dopaminergic degeneration in rotenone-treated mice","volume":"55","author":"Inden","year":"2009","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.bbi.2026.106840_b0150","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/978-1-4939-9465-6_4","article-title":"Neuroprotection in traumatic brain injury","author":"Jain","year":"2019","journal-title":"Handbook Neuroprotection"},{"key":"10.1016\/j.bbi.2026.106840_b0155","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1741-7007-2-22","article-title":"Low dose pramipexole is neuroprotective in the MPTP mouse model of Parkinson's disease, and downregulates the dopamine transporter via the D3 receptor","volume":"2","author":"Joyce","year":"2004","journal-title":"BMC Biol."},{"issue":"10","key":"10.1016\/j.bbi.2026.106840_b0160","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1002\/mds.26307","article-title":"Colonic bacterial composition in Parkinson's disease","volume":"30","author":"Keshavarzian","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbi.2026.106840_b0165","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1089\/ars.2010.3671","article-title":"Inhaled hydrogen sulfide prevents neurodegeneration and movement disorder in a mouse model of Parkinson's disease","volume":"15","author":"Kida","year":"2011","journal-title":"Antioxid. Redox Signal."},{"key":"10.1016\/j.bbi.2026.106840_b0170","first-page":"3","article-title":"Parkinson\u2019s disease: etiology, neuropathology, and pathogenesis","author":"Kouli","year":"2018","journal-title":"Exon Publ."},{"issue":"7378","key":"10.1016\/j.bbi.2026.106840_b0175","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nature10648","article-title":"Floor plate-derived dopamine neurons from hESCs efficiently engraft in animal models of PD","volume":"480","author":"Kriks","year":"2011","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.bbi.2026.106840_b0180","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-018-1248-8","article-title":"Parkinson\u2019s disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1\/Th2\/T17 and Treg in drug-naive and drug-treated patients","volume":"15","author":"Kustrimovic","year":"2018","journal-title":"J. Neuroinflam."},{"issue":"10","key":"10.1016\/j.bbi.2026.106840_b0185","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/j.tins.2023.07.005","article-title":"The systemic immune response in Parkinson\u2019s disease: focus on the peripheral immune component","volume":"46","author":"Lauritsen","year":"2023","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.bbi.2026.106840_b0190","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s007020070030","article-title":"Antioxidant property of pramipexole independent of dopamine receptor activation in neuroprotection","volume":"107","author":"Le","year":"2000","journal-title":"J. Neural Transm."},{"key":"10.1016\/j.bbi.2026.106840_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2021.112458","article-title":"Dopamine, a co-regulatory component, bridges the central nervous system and the immune system","volume":"145","author":"Li","year":"2022","journal-title":"Biomed. Pharmacother."},{"issue":"8","key":"10.1016\/j.bbi.2026.106840_b0200","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.14336\/AD.2021.0418","article-title":"Intestinal inflammation and Parkinson\u2019s disease","volume":"12","author":"Li","year":"2021","journal-title":"Aging Dis."},{"issue":"2","key":"10.1016\/j.bbi.2026.106840_b0205","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s12035-016-9717-5","article-title":"Pramipexole, a dopamine D2\/D3 receptor-preferring agonist, prevents experimental autoimmune encephalomyelitis development in mice","volume":"54","author":"Lieberknecht","year":"2017","journal-title":"Mol. Neurobiol."},{"issue":"7","key":"10.1016\/j.bbi.2026.106840_b0210","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.3390\/ijms22073781","article-title":"Polymorphisms of dopamine receptor genes and Parkinson\u2019s disease: clinical relevance and future perspectives","volume":"22","author":"Magistrelli","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"9","key":"10.1016\/j.bbi.2026.106840_b0215","doi-asserted-by":"crossref","first-page":"4971","DOI":"10.1073\/pnas.1913904117","article-title":"The process of Lewy body formation, rather than simply \u03b1-synuclein fibrillization, is one of the major drivers of neurodegeneration","volume":"117","author":"Mahul-Mellier","year":"2020","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.bbi.2026.106840_b0225","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1002\/mds.27304","article-title":"A controversy on the role of short-chain fatty acids in the pathogenesis of Parkinson's disease","volume":"33","author":"Mulak","year":"2018","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbi.2026.106840_b0230","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jneuroim.2019.02.007","article-title":"Dopamine inhibits human CD8+ Treg function through D1-like dopaminergic receptors","volume":"332","author":"Nasi","year":"2019","journal-title":"J. Neuroimmunol."},{"issue":"3","key":"10.1016\/j.bbi.2026.106840_b0235","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/eji.202048614","article-title":"CD8+ Tregs revisited: a heterogeneous population with different phenotypes and properties","volume":"51","author":"Niederlova","year":"2021","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.bbi.2026.106840_b0240","doi-asserted-by":"crossref","DOI":"10.1002\/mds.28119","article-title":"Meta-Analysis of Gut Dysbiosis in Parkinson's Disease","author":"Nishiwaki","year":"2020","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbi.2026.106840_b0245","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.neuroscience.2017.08.023","article-title":"An altered blood-brain barrier contributes to brain iron accumulation and neuroinflammation in the 6-OHDA rat model of Parkinson\u2019s disease","volume":"362","author":"Olmedo-D\u00edaz","year":"2017","journal-title":"Neuroscience"},{"key":"10.1016\/j.bbi.2026.106840_b0250","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11011-020-00636-w","article-title":"Current and emerging therapeutic targets for Parkinson\u2019s disease","volume":"36","author":"Pingale","year":"2021","journal-title":"Metab. Brain Dis."},{"issue":"4","key":"10.1016\/j.bbi.2026.106840_b0265","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1007\/s11481-012-9402-z","article-title":"CD4+ regulatory and effector\/memory T cell subsets profile motor dysfunction in Parkinson\u2019s disease","volume":"7","author":"Saunders","year":"2012","journal-title":"J. Neuroimmune Pharmacol."},{"issue":"1","key":"10.1016\/j.bbi.2026.106840_b0270","first-page":"1","article-title":"Ex vivo expansion of dysfunctional regulatory T lymphocytes restores suppressive function in Parkinson\u2019s disease","volume":"7","author":"Thome","year":"2021","journal-title":"npj Parkinson's Dis."},{"issue":"2","key":"10.1016\/j.bbi.2026.106840_b0275","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3233\/NIB-2012-012044","article-title":"Role of peripheral and brain-derived dopamine (DA) in immune regulation","volume":"3","author":"T\u00f3th","year":"2012","journal-title":"Adv. Neuroimmune Biol."},{"key":"10.1016\/j.bbi.2026.106840_b0280","doi-asserted-by":"crossref","unstructured":"Vieyra R, Vela J, Montiel L, L\u00f3pez R, Moreno MC.(2018). Description of CD8+ Regulatory T Lymphocytes and Their Specific Intervention in Graft-versus-Host and Infectious Diseases, Autoimmunity, and Cancer. J. Immunol. Res. 2018;2018:3758713. doi: 10.1155\/2018\/3758713.","DOI":"10.1155\/2018\/3758713"},{"issue":"5","key":"10.1016\/j.bbi.2026.106840_b0285","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1172\/JCI84181","article-title":"NADPH oxidase deficiency underlies dysfunction of aged CD8+ Tregs","volume":"126","author":"Wen","year":"2016","journal-title":"J. Clin. Invest."},{"issue":"17","key":"10.1016\/j.bbi.2026.106840_b0290","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1021\/acschemneuro.0c00332","article-title":"Classics in chemical neuroscience: pramipexole","volume":"11","author":"Wilson","year":"2020","journal-title":"ACS Chem. Nerosci."},{"key":"10.1016\/j.bbi.2026.106840_bib301","doi-asserted-by":"crossref","first-page":"105908","DOI":"10.1016\/j.intimp.2019.105908","article-title":"The modulatory role of dopamine receptors in brain neuroinflammation","volume":"76","author":"Xia","year":"2019","journal-title":"International Immunopharmacology"},{"issue":"6","key":"10.1016\/j.bbi.2026.106840_b0295","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.molcel.2021.01.003","article-title":"Structures of the human dopamine D3 receptor-Gi complexes","volume":"81","author":"Xu","year":"2021","journal-title":"Mol. Cell"},{"key":"10.1016\/j.bbi.2026.106840_b0300","doi-asserted-by":"crossref","first-page":"2972","DOI":"10.12659\/MSM.904240","article-title":"Increased levels of pro-inflammatory and anti-inflammatory cellular responses in Parkinson\u2019s disease patients: search for a disease indicator","volume":"23","author":"Yang","year":"2017","journal-title":"Med. Sci. Monit.: Int. Med. J. Exp. Clin. Res."}],"container-title":["Brain, Behavior, and Immunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088915912600588X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S088915912600588X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:46:29Z","timestamp":1789472789000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S088915912600588X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":57,"alternative-id":["S088915912600588X"],"URL":"https:\/\/doi.org\/10.1016\/j.bbi.2026.106840","relation":{},"ISSN":["0889-1591"],"issn-type":[{"value":"0889-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pramipexole promotes CD8+ regulatory T cell-dependent neuroprotection in Parkinson\u2019s disease patients","name":"articletitle","label":"Article Title"},{"value":"Brain, Behavior, and Immunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbi.2026.106840","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"106840"}}